TSTickerStar
Company alerts/ARMP
ARMP company alerts

ARMP updates worth following

TickerStar monitors official filings, investor releases, earnings, and call updates for ARMP. Subscribe to ARMP alerts to receive concise, source-linked alerts when TickerStar detects a meaningful company update.

Official-source feed

Recent ARMP alert previews

TickerStar filters routine noise and surfaces investor-relevant filings, releases, earnings, and call updates.

EarningsOfficial company source

Armata reports Q3 2026 results; net income driven by convertible loan fair value gain

Armata Pharmaceuticals reported grant and award revenue of $3.171 million for the three months ended September 30, 2026 versus $1.159 million in the comparable 2025 period, and a loss from operations of $7.383 million compared with a $7.776 million loss a year earlier. Net income was $54.857 million ($1.15 basic; $(0.24) diluted), primarily driven by a $69.595 million non-cash gain from the change in fair value of the convertible loan, versus a $26.675 million net loss in the comparable 2025 period. Nine-month r...

Read source-backed brief
SEC filingSEC filing

ARMP 10-Q filed 2026-11-12 | Key takeaways

ARMP filed its 10-Q; the most relevant disclosure change is expanded MTEC Award: The MTEC Agreement was modified on September 18, 2026 to increase the total award by $3.7 million to $32.4 million and extend the term to December 31, 2026; the award supports the AP-SA02 Phase 3 preparation activities.

Read source-backed brief